Report cover image

Europe Cellulite Treatment Market Size, Share & Trends Analysis Report By Gender (Female and Male), By Procedure Type, By Cellulite Type, By End User (Clinics & Beauty Centers, Hospitals and Others), By Country and Growth Forecast, 2024 - 2031

Publisher Knowledge Based Value (KBV) Research
Published Apr 11, 2024
Length 129 Pages
SKU # KBV18699542

Description

Europe Cellulite Treatment Market Size, Share & Trends Analysis Report By Gender (Female and Male), By Procedure Type, By Cellulite Type, By End User (Clinics & Beauty Centers, Hospitals and Others), By Country and Growth Forecast, 2024 - 2031


The Europe Cellulite Treatment Market would witness market growth of 9.9% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Cellulite Treatment Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $349.6 Million by 2031. The UK market is exhibiting a CAGR of 8.9% during (2024 - 2031). Additionally, The France market would experience a CAGR of 10.7% during (2024 - 2031).

In recent years, skincare products targeting cellulite are also gaining popularity. Some of the ingredients in these products, including caffeine, retinol, and antioxidants, claim to diminish the appearance of cellulite. Caffeine is frequently incorporated into cellulite-targeting skincare products on account of its capacity to reduce fluid retention and enhance circulation, thereby potentially aiding in the reduction of cellulite appearance. Another popular ingredient, retinol, which is a form of vitamin A, is thought to increase skin texture and stimulate collagen production, thereby diminishing the appearance of cellulite. Because they prevent skin damage and enhance general well-being, cellulite-targeting skincare products frequently incorporate antioxidants, including vitamins C and E.

Moreover, the increased prevalence of social media and influencer marketing has contributed to heightened consciousness and endorsement of skincare products that purport to diminish the visual appearance of cellulite. Additionally, the convenience and accessibility of skin care products make them a popular choice for consumers looking to address their cellulite concerns. Skincare products can be easily incorporated into a daily skincare routine and purchased over the counter or online, making them a convenient option for consumers.

The increasing demand for cellulite treatment in Europe can be linked to the high prevalence of overweight adults and physical inactivity in the region. According to Eurostat, the proportion of overweight adults in the EU varied between 37% in Italy and 58% in Croatia for women and between 53% in France and 73% in Croatia for men. Thus, the high prevalence of overweight adults and physical inactivity in Europe suggests a significant potential market for cellulite treatments.

Based on Gender, the market is segmented into Female and Male. Based on Procedure Type, the market is segmented into Non-invasive, Topical, and Minimally Invasive. Based on Cellulite Type, the market is segmented into Soft Cellulite, Hard Cellulite and Edematous. Based on End User, the market is segmented into Clinics & Beauty Centers, Hospitals and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled
  • Candela Corporation (Syneron Medical)
  • Bausch Health Companies, Inc.
  • Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.)
  • AbbVie, Inc.
  • Cynosure, LLC (Clayton, Dubilier & Rice, LLC)
  • Hologic, Inc.
  • Galderma S.A.
  • Zimmer MedizinSysteme GmbH
  • Endo International PLC
  • Merz Pharma GmbH & Co. KGaA
Europe Cellulite Treatment Market Report Segmentation

By Gender
  • Female
  • Male
By Procedure Type
  • Non-invasive
  • Topical
  • Minimally Invasive
By Cellulite Type
  • Soft Cellulite
  • Hard Cellulite
  • Edematous
By End User
  • Clinics & Beauty Centers
  • Hospitals
  • Others
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Table of Contents

129 Pages
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Cellulite Treatment Market, by Gender
1.4.2 Europe Cellulite Treatment Market, by Procedure Type
1.4.3 Europe Cellulite Treatment Market, by Cellulite Type
1.4.4 Europe Cellulite Treatment Market, by End User
1.4.5 Europe Cellulite Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Recent Strategies Deployed in Cellulite Treatment Market
Chapter 5. Europe Cellulite Treatment Market by Gender
5.1 Europe Female Market by Country
5.2 Europe Male Market by Country
Chapter 6. Europe Cellulite Treatment Market by Procedure Type
6.1 Europe Non-invasive Market by Country
6.2 Europe Topical Market by Country
6.3 Europe Minimally Invasive Market by Country
Chapter 7. Europe Cellulite Treatment Market by Cellulite Type
7.1 Europe Soft Cellulite Market by Country
7.2 Europe Hard Cellulite Market by Country
7.3 Europe Edematous Market by Country
Chapter 8. Europe Cellulite Treatment Market by End User
8.1 Europe Clinics & Beauty Centers Market by Country
8.2 Europe Hospitals Market by Country
8.3 Europe Others Market by Country
Chapter 9. Europe Cellulite Treatment Market by Country
9.1 Germany Cellulite Treatment Market
9.1.1 Germany Cellulite Treatment Market by Gender
9.1.2 Germany Cellulite Treatment Market by Procedure Type
9.1.3 Germany Cellulite Treatment Market by Cellulite Type
9.1.4 Germany Cellulite Treatment Market by End User
9.2 UK Cellulite Treatment Market
9.2.1 UK Cellulite Treatment Market by Gender
9.2.2 UK Cellulite Treatment Market by Procedure Type
9.2.3 UK Cellulite Treatment Market by Cellulite Type
9.2.4 UK Cellulite Treatment Market by End User
9.3 France Cellulite Treatment Market
9.3.1 France Cellulite Treatment Market by Gender
9.3.2 France Cellulite Treatment Market by Procedure Type
9.3.3 France Cellulite Treatment Market by Cellulite Type
9.3.4 France Cellulite Treatment Market by End User
9.4 Russia Cellulite Treatment Market
9.4.1 Russia Cellulite Treatment Market by Gender
9.4.2 Russia Cellulite Treatment Market by Procedure Type
9.4.3 Russia Cellulite Treatment Market by Cellulite Type
9.4.4 Russia Cellulite Treatment Market by End User
9.5 Spain Cellulite Treatment Market
9.5.1 Spain Cellulite Treatment Market by Gender
9.5.2 Spain Cellulite Treatment Market by Procedure Type
9.5.3 Spain Cellulite Treatment Market by Cellulite Type
9.5.4 Spain Cellulite Treatment Market by End User
9.6 Italy Cellulite Treatment Market
9.6.1 Italy Cellulite Treatment Market by Gender
9.6.2 Italy Cellulite Treatment Market by Procedure Type
9.6.3 Italy Cellulite Treatment Market by Cellulite Type
9.6.4 Italy Cellulite Treatment Market by End User
9.7 Rest of Europe Cellulite Treatment Market
9.7.1 Rest of Europe Cellulite Treatment Market by Gender
9.7.2 Rest of Europe Cellulite Treatment Market by Procedure Type
9.7.3 Rest of Europe Cellulite Treatment Market by Cellulite Type
9.7.4 Rest of Europe Cellulite Treatment Market by End User
Chapter 10. Company Profiles
10.1 Candela corporation (Syneron Medical)
10.1.1 Company Overview
10.1.2 Recent strategies and developments:
10.1.2.1 Partnerships, Collaborations, and Agreements:
10.1.2.2 Product Launches and Product Expansions:
10.1.3 SWOT Analysis
10.2 Bausch Health Companies, Inc
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Trials and Approvals:
10.2.6 SWOT Analysis
10.3 Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.)
10.3.1 Company Overview
10.3.2 Recent strategies and developments:
10.3.2.1 Partnerships, Collaborations, and Agreements:
10.3.2.2 Product Launches and Product Expansions:
10.3.3 SWOT Analysis
10.4 AbbVie, Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Regional Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Product Launches and Product Expansions:
10.4.5.2 Acquisition and Mergers:
10.4.6 SWOT Analysis
10.5 Hologic, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expenses
10.5.5 SWOT Analysis
10.6 Galderma S.A.
10.6.1 Company Overview
10.6.2 SWOT Analysis
10.7 Endo International PLC
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental Analysis
10.7.4 Research & Development Expense
10.7.5 Recent strategies and developments:
10.7.5.1 Trials and Approvals:
10.7.5.2 Acquisition and Mergers:
10.7.6 SWOT Analysis
10.8 Merz Pharma GmbH & Co. KGaA
10.8.1 Company Overview
10.8.2 SWOT Analysis
10.9 Cynosure, LLC (Clayton, Dubilier & Rice, LLC)
10.9.1 Company Overview
10.9.2 SWOT Analysis
10.10. Zimmer MedizinSysteme GmbH
10.10.1 Company Overview
10.10.2 SWOT Analysis

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us